Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Current Research Studies

Phase 3, multicenter, open-label study to assess the long-term safety and tolerability of rimegepant for the acute treatment of migraine (with or without aura) in children and adolescents ≥ 6 to < 18 years of age

Rimegepant 312

Phase: III
Clinicaltrials.gov ID: NCT04743141

What is the goal of the study?

To evaluate the safety and tolerability of rimegepant in children and adolescents (age ≥ 6 to < 18 years of age).

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Heidi Blume
Study Team Member: Mikaela Morales, [email protected]